Lentiviral-mediated RNA interference
- PMID: 12542850
- DOI: 10.1089/104303402320987888
Lentiviral-mediated RNA interference
Abstract
RNA interference (RNAi) is a form of posttranscriptional gene silencing mediated by short double-stranded RNA, known as small interfering RNA (siRNA). These siRNAs are capable of binding to a specific mRNA sequence and causing its degradation. The recent demonstration of a plasmid vector that directs siRNA synthesis in mammalian cells prompted us to examine the ability of lentiviral vectors to encode siRNA as a means of providing long-term gene silencing in mammalian cells. The RNA-polymerase III dependent promoter (H1-RNA promoter) was inserted in the lentiviral genome to drive the expression of a small hairpin RNA (shRNA) against enhanced green fluorescent protein (EGFP). This construct successfully silenced EGFP expression in two stable cell lines expressing this protein, as analyzed by fluorescence microscopy, flow cytometry, and Western blotting. The silencing, which is dose dependent, occurs as early as 72 hr postinfection and persists for at least 25 days postinfection. The ability of lentiviruses encoding siRNA to silence genes specifically makes it possible to take full advantage of the possibilities offered by the lentiviral vector and provides a powerful tool for gene therapy and gene function studies.
Similar articles
-
Construction of simple and efficient DNA vector-based short hairpin RNA expression systems for specific gene silencing in mammalian cells.Methods Mol Biol. 2007;408:223-41. doi: 10.1007/978-1-59745-547-3_13. Methods Mol Biol. 2007. PMID: 18314586
-
Stable RNA interference: comparison of U6 and H1 promoters in endothelial cells and in mouse brain.J Gene Med. 2006 Apr;8(4):433-41. doi: 10.1002/jgm.860. J Gene Med. 2006. PMID: 16389634
-
Effects of RNA interference-mediated NRP-1 silencing on the proliferation and apoptosis of breast cancer cells.Mol Med Rep. 2015 Jul;12(1):513-9. doi: 10.3892/mmr.2015.3405. Epub 2015 Mar 3. Mol Med Rep. 2015. PMID: 25738638
-
Vectors for RNA interference.Curr Opin Mol Ther. 2004 Aug;6(4):367-72. Curr Opin Mol Ther. 2004. PMID: 15468595 Review.
-
Nonviral vector-mediated RNA interference: its gene silencing characteristics and important factors to achieve RNAi-based gene therapy.Adv Drug Deliv Rev. 2009 Jul 25;61(9):760-6. doi: 10.1016/j.addr.2009.04.006. Epub 2009 Apr 20. Adv Drug Deliv Rev. 2009. PMID: 19386274 Review.
Cited by
-
Comparison of Lentiviral Packaging Mixes and Producer Cell Lines for RNAi Applications.Mol Biotechnol. 2015 Jun;57(6):499-505. doi: 10.1007/s12033-015-9843-8. Mol Biotechnol. 2015. PMID: 25616840
-
Illuminating the gateway of gene silencing: perspective of RNA interference technology in clinical therapeutics.Mol Biotechnol. 2012 Jul;51(3):289-302. doi: 10.1007/s12033-011-9456-9. Mol Biotechnol. 2012. PMID: 21947958 Free PMC article. Review.
-
A microRNA profile of human CD8(+) regulatory T cells and characterization of the effects of microRNAs on Treg cell-associated genes.J Transl Med. 2014 Aug 6;12:218. doi: 10.1186/s12967-014-0218-x. J Transl Med. 2014. PMID: 25090912 Free PMC article.
-
Lentiviral RNAi-induced downregulation of adenosine kinase in human mesenchymal stem cell grafts: a novel perspective for seizure control.Exp Neurol. 2007 Nov;208(1):26-37. doi: 10.1016/j.expneurol.2007.07.016. Epub 2007 Aug 2. Exp Neurol. 2007. PMID: 17716659 Free PMC article.
-
Gene modulation for treating liver fibrosis.Crit Rev Ther Drug Carrier Syst. 2007;24(2):93-146. doi: 10.1615/critrevtherdrugcarriersyst.v24.i2.10. Crit Rev Ther Drug Carrier Syst. 2007. PMID: 17725523 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources